Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 67 articles:
HTML format
Text format



Single Articles


    May 2017
  1. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available


    March 2017
  2. PATIDAR KR, Thacker LR, Wade JB, White MB, et al
    Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis.
    Dig Dis Sci. 2017 Mar 3. doi: 10.1007/s10620-017-4509.
    PubMed     Text format     Abstract available


  3. KALAFATELI M, Zisimopoulos K, Vourli G, Rigamonti C, et al
    Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
    Dig Dis Sci. 2017 Mar 1. doi: 10.1007/s10620-017-4504.
    PubMed     Text format     Abstract available


    February 2017
  4. KIM G, Huh JH, Lee KJ, Kim MY, et al
    Relative Adrenal Insufficiency in Patients with Cirrhosis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017 Feb 7. doi: 10.1007/s10620-017-4471.
    PubMed     Text format     Abstract available


    January 2017
  5. HUNG TH, Tseng CW, Tsai CC, Hsieh YH, et al
    Mortality Following Catheter Drainage Versus Thoracentesis in Cirrhotic Patients with Pleural Effusion.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4463.
    PubMed     Text format     Abstract available


    December 2016
  6. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Text format     Abstract available


  7. GOOSSENS N, Breguet R, De Vito C, Terraz S, et al
    Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4421.
    PubMed     Text format     Abstract available


    November 2016
  8. HWANG GL, Sze DY
    Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  9. WALLING AM, Ahluwalia SC, Wenger NS, Booth M, et al
    Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    October 2016
  10. TSOU YK, Liu CY, Fu KI, Lin CH, et al
    Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  11. ALLEGRETTI AS, Ortiz G, Kalim S, Wibecan J, et al
    Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  12. DONG T, Aronsohn A, Gautham Reddy K, Te HS, et al
    Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    August 2016
  13. HOEFS JC
    Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  14. LIU TL, Trogdon J, Weinberger M, Fried B, et al
    Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  15. KAPLAN DE, Dai F, Skanderson M, Aytaman A, et al
    Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  16. SCLAIR SN, Carrasquillo O, Czul F, Trivella JP, et al
    Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  17. CAMUS M, Khungar V, Jensen DM, Ohning GV, et al
    Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    May 2016
  18. ASCHA M, Hanouneh M, S Ascha M, Zein NN, et al
    Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease >/=15.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  19. KASWALA DH, Lai M, Afdhal NH
    Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016.
    Dig Dis Sci. 2016;61:1356-64.
    PubMed     Text format     Abstract available


  20. GOH GB, McCullough AJ
    Natural History of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1226-33.
    PubMed     Text format     Abstract available


  21. ABDOU RM, Zhu L, Baker RD, Baker SS, et al
    Gut Microbiota of Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016;61:1268-81.
    PubMed     Text format     Abstract available


    April 2016
  22. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  23. BRUNS T, Reuken PA, Stengel S, Gerber L, et al
    NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format    


  24. TAN HK, James PD, Wong F
    Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    March 2016
  25. SARGENTI K, Johansson A, Bertilsson S, Mattsby-Baltzer I, et al
    Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  26. CHO SB, Choi YH, So YH, Ahn DW, et al
    Balloon-Occluded Retrograde Transvenous Obliteration of Jejunal Varices: A Case Report, Therapeutic Approach.
    Dig Dis Sci. 2016;61:948-51.
    PubMed     Text format    


  27. PIMENTEL CF, Jiang ZG, Otsubo T, Feldbrugge L, et al
    Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH.
    Dig Dis Sci. 2016;61:905-12.
    PubMed     Text format     Abstract available


    January 2016
  28. PATEL YA, Berg CL, Moylan CA
    Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  29. INTAGLIATA NM, Henry ZH, Maitland H, Shah NL, et al
    Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  30. BORHOFEN SM, Gerner C, Lehmann J, Fimmers R, et al
    The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  31. HA J, Hendrix M, Guyer AG
    Microwave Ablation for the Treatment of Hypersplenism: Short Waves, Low Cost, Big Results.
    Dig Dis Sci. 2016;61:6-7.
    PubMed     Text format    


  32. FLEMMING JA, Saxena V, Shen H, Terrault NA, et al
    Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Dig Dis Sci. 2016;61:62-9.
    PubMed     Text format     Abstract available


    December 2015
  33. AN J, Zheng L, Xie S, Yin F, et al
    Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2015
  34. PARK CH, Han DS, Jeong JY, Eun CS, et al
    Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  35. ROGAL SS, Yan P, Rimland D, Re VL 3rd, et al
    Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    October 2015
  36. POP A, Procopet B, Stefanescu H, Cavasi A, et al
    Clostridium Difficile Screening in Cirrhosis: One for All, or Some for One?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    September 2015
  37. MACHADO MV, Kruger L, Jewell ML, Michelotti GA, et al
    Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  38. RUNYON B, Mitroi L
    Do Automated Telephone Systems Decrease Hospital Readmissions Among Patients with Cirrhosis?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    August 2015
  39. MANGRAY S, Zweit J, Puri P
    Zinc Deficiency in Cirrhosis: Micronutrient for Thought?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  40. PERUMPAIL RB, Wong RJ, Ahmed A, Harrison SA, et al
    Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    July 2015
  41. VINDIGNI SM, Surawicz CM
    Cirrhosis and C. difficile: A Deadly Duo?
    Dig Dis Sci. 2015.
    PubMed     Text format    


  42. MINDIKOGLU AL, Dowling TC, Schaub DJ, Hutson WR, et al
    Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  43. NIELSEN MJ, Lehmann J, Leeming DJ, Schierwagen R, et al
    Circulating Elastin Fragments Are Not Affected by Hepatic, Renal and Hemodynamic Changes, But Reflect Survival in Cirrhosis with TIPS.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  44. DYAL HK, Aguilar M, Bhuket T, Liu B, et al
    Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  45. XUE Y, Michalopoulos G
    Tregs: A Therapeutic Target for the Treatment of Portal Fibrosis?
    Dig Dis Sci. 2015;60:1878-80.
    PubMed     Text format    


  46. JUAREZ-HERNANDEZ E, Uribe-Ramos MH, Ramos-Ostos MH, Lopez-Ramirez AY, et al
    Factors Associated with the Quality of Transient Elastography.
    Dig Dis Sci. 2015;60:2177-82.
    PubMed     Text format     Abstract available


  47. JOHNSON KB, Mueller JL, Simon TG, Zheng H, et al
    Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.
    Dig Dis Sci. 2015;60:2190-5.
    PubMed     Text format     Abstract available


  48. WANG Q, Wen R, Lin Q, Wang N, et al
    Wogonoside Shows Antifibrotic Effects in an Experimental Regression Model of Hepatic Fibrosis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    June 2015
  49. CASADO JL, Esteban MA, Banon S, Moreno A, et al
    Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  50. MOLLER S, Bendtsen F
    Cirrhotic Multiorgan Syndrome.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  51. THOMSON M, Volk M, Kim HM, Piette JD, et al
    An Automated Telephone Monitoring System to Identify Patients with Cirrhosis at Risk of Re-hospitalization.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  52. JIANG X, Gao F, Ma Y, Feng S, et al
    Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  53. GOH GB, Pagadala MR, Dasarathy J, Unalp-Arida A, et al
    Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in nonalcoholic Fatty liver disease.
    Dig Dis Sci. 2015;60:1825-31.
    PubMed     Text format     Abstract available


    May 2015
  54. CZAJA AJ
    Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  55. DEFILIPPIS EM, Kumar S
    Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  56. SAAB S, Alper T, Sernas E, Pruthi P, et al
    Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  57. FOX RK
    Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  58. LUTZ HH, Schroeter B, Kroy DC, Neumann U, et al
    Doppler Ultrasound and Transient Elastography in Liver Transplant Patients for Noninvasive Evaluation of Liver Fibrosis in Comparison with Histology: A Prospective Observational Study.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    April 2015
  59. LUO F, Ishigami M, Achiwa K, Ishizu Y, et al
    Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  60. COREY KE, Misdraji J, Gelrud L, King LY, et al
    Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    February 2015
  61. LU CH, Hou QR, Deng LF, Fei C, et al
    MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    January 2015
  62. WONG VW, Lampertico P, de Ledinghen V, Chang PE, et al
    Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    December 2014
  63. MANSOOR S, Yerian L, Kohli R, Xanthakos S, et al
    The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  64. TANG Y
    Curcumin Targets Multiple Pathways to Halt Hepatic Stellate Cell Activation: Updated Mechanisms In Vitro and In Vivo.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


    November 2014
  65. ZHANG K, Jiang L, Jia Z, Zhang Y, et al
    Radiofrequency Ablation Plus Devascularization Is the Preferred Treatment of Hepatocellular Carcinoma with Esophageal Varices.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  66. ROH YS, Park S, Lim CW, Kim B, et al
    Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  67. BORZIO M, Dionigi E, Rossini A, Toldi A, et al
    Trend of Improving Prognosis of Hepatocellular Carcinoma in Clinical Practice: An Italian In-Field Experience.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: